|
Nashville, Tennessee (July 21, 2005) - Renal Care Group, Inc. (NYSE:
RCI) announced today that it will have a Special Meeting of Shareholders
on Wednesday, August 24, 2005. The Special Meeting will be held at 9:00
a.m. CDT at the Nashville Marriott at Vanderbilt University in Nashville,
Tennessee. At the Special Meeting, shareholders of record as of July 1,
2005, will vote on a proposal to adopt the agreement dated May 3, 2005
under which Fresenius Medical Care AG will acquire Renal Care Group, Inc.
for $48.00 per common share.
Renal Care Group, Inc. is a specialized dialysis services company that
provides care to patients with kidney disease. The Company serves over
31,000 patients at more than 445 outpatient dialysis facilities in addition
to providing acute dialysis services at more than 210 hospitals. Over
9,100 associates provide services across the Company's 34-state network.
More information about Renal Care Group, Inc. may be found at www.renalcaregroup.com.
Certain statements in this press release, particularly statements about
the acquisition of Renal Care Group by Fresenius Medical Care, constitute
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements, which
are usually preceded by words like believe, expect, plan, intend, will
and the like, include statements regarding the transaction with Fresenius
Medical Care and any other statements that necessarily depend on future
events. These forward-looking statements reflect management's expectations
and are based upon currently available information. These forward-looking
statements involve known and unknown risks, uncertainties and other factors
that may cause actual results, performance or achievements of Renal Care
Group to differ materially from those expressed in or implied by the forward-looking
statements, including risks related to: the consummation of the transaction
between Renal Care Group and Fresenius Medical Care, the dependence of
our profits on the services we provide to a small portion of our patients
with private insurance; changes in the Medicare and Medicaid programs;
changes in the health care delivery, financing or reimbursement systems;
risks related to the drug Epogen (EPO); compliance with health care and
other applicable laws; and dependence on executive officers. These and
other factors affecting the Company are discussed in more detail in Renal
Care Group's reports filed with the Securities and Exchange Commission,
including without limitation Renal Care Group's most recent annual report
on Form 10-K and any quarterly reports on Form 10-Q filed after that annual
report. Copies of these filings are available from Renal Care Group upon
request.
CONTACT: Renal Care Group Inc., Nashville
Terry Proveaux, 615-345-5577
www.renalcaregroup.com |
Press Releases